You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨國金證券:維持華潤三九“買入”評級,處方藥板塊趨勢向好
格隆匯 03-14 15:17

國金證券研報指出,華潤三九(000999.SZ)24年歸母淨利潤33.68億元(同比+18.05%),扣非歸母淨利潤31.18億元(同比+15.01%)。24年公司CHC業務實現收入124.8億元,同比+14.13%。零售環境雖然承壓,但公司通過豐富產品組合、更迭品牌傳播方式、強化渠道協同等方式,促進CHC業務穩健增長。國藥業務未來有望通過積極擁抱集採,逐步實現以價換量,提升市場份額。公司併購整合持續發力,整體實力穩步增強。公司CHC業務有望穩健增長,處方藥板塊趨勢向好,併購整合成效逐步顯現。維持“買入”評級。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account